295 related articles for article (PubMed ID: 16495833)
1. [Epidemiology of anti-D allo-immunization during pregnancy].
Branger B; Winer N
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the efficacy of different methods for the prevention of anti-D allo-immunization during pregnancy: targeted strategy limited to risk situations or associated with systematic prevention in the 3rd trimester].
Parant O
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S93-1S103. PubMed ID: 16495834
[TBL] [Abstract][Full Text] [Related]
4. [Adverse effects and patient information].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
[TBL] [Abstract][Full Text] [Related]
5. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
Cortey A; Brossard Y; Beliard R; Bourel D
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
[TBL] [Abstract][Full Text] [Related]
7. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
Daniels G; Finning K; Martin P; Summers J
Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
[TBL] [Abstract][Full Text] [Related]
8. [Economic analysis of the prevention of anti-D immunization].
Ravinet J; Carbonne B
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S104-1S111. PubMed ID: 16495835
[TBL] [Abstract][Full Text] [Related]
9. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization].
Mannessier L
Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695
[TBL] [Abstract][Full Text] [Related]
10. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
[TBL] [Abstract][Full Text] [Related]
11. [Advantages of preventing Rh isoimmunization].
Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N
Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466
[TBL] [Abstract][Full Text] [Related]
12. RhD haemolytic disease of the fetus and the newborn.
Urbaniak SJ; Greiss MA
Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
[TBL] [Abstract][Full Text] [Related]
13. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
Sainio S; Kuosmanen M
Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
[TBL] [Abstract][Full Text] [Related]
14. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
15. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
16. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
17. Relevance of new recommendations on routine antenatal prevention of rhesus immunization: an appraisal based on a retrospective analysis of all cases observed in two French administrative areas of 3 million inhabitants.
Boulet S; Krause C; Tixier H; Bardou M; Sagot P
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):65-70. PubMed ID: 19482403
[TBL] [Abstract][Full Text] [Related]
18. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
19. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
Zavala C; Salamanca F
Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
[TBL] [Abstract][Full Text] [Related]
20. [Immunohematological surveillance of the pregnant woman: new prevention policy].
Mannessier L
Transfus Clin Biol; 2009 May; 16(2):195-200. PubMed ID: 19419894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
